Study ID: FSS-AS-305
Study Title
- Long-Term Safety Study of Fluticasone Propionate (Fp) Multidose Dry Powder Inhaler (MDPI) and Fluticasone Propionate/Salmeterol (FS) MDPI in Patients With Persistent Asthma
Teva Identifier
- FSS-AS-305
ClinicalTrials.gov Identifier
- NCT02175771
Study Status
- Completed
Trial Condition(s)
- Persistent Asthma
Interventions
- Drug: Fp MDPI | Drug: FS MDPI | Drug: FLOVENT HFA | Drug: ADVAIR DISKUS | Drug: albuterol/salbutamol HFA
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 12 Years and older
Trial Duration
- 07/01/2014 - 07/01/2015
Phase
- Phase 3
Study Type
Interventional
